Back to Awarded Treatment Trials


Awarded Trial: 11T-013

Grant ID

11T-013

Illness

Schizophrenia

Primary Drug/Intervention

minocycline

Primary Dosage

200 mg/day

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Enrolling

Investigator

Fekadu

Sample Size

150

Duration of Study Period for Each Subject

8 weeks

Outcome Measurements

Change in symptom severity meaured by PANSS

Results

N/A

Publication

N/A

Link

N/A

PI Name

Abebaw Fekadu

Degree

MD

Center

School of Medicine, College of Health Sciences

Institution

Addis Ababa University

Address

Department of Psychiatry

City or Town

N/A

State or Province

N/A

Zip or Postal Code

N/A

Country

N/A

Email Address

abe.wassie@kcl.ac.uk